Virtu Financial LLC Avenue Therapeutics, Inc. Transaction History

Virtu Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$0.22 - $0.56 $12,760 - $32,482	-58,004 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$0.22 - $0.96 $12,760 - $55,683	58,004 New	58,004 $28,000
Q3 2021 Nov 12, 2021	SELL	$1.48 - $2.65 $39,032 - $69,888	-26,373 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$2.41 - $7.11 $63,558 - $187,512	26,373 New	26,373 $66,000
Q1 2021 May 19, 2021	SELL	$4.7 - $7.17 $82,104 - $125,252	-17,469 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$2.95 - $11.04 $51,533 - $192,857	17,469 New	17,469 $104,000
Q1 2018 May 14, 2018	SELL	$3.64 - $5.75 $57,937 - $91,522	-15,917 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$3.53 - $5.64 $56,187 - $89,771	15,917	15,917 $58,000

Ticker ATXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,127,720
Market Cap $8.13M
Description
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was in...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.